Screen time and anxiety, global pain levels, d-dimer and DVT, and tertiary patients

Written By Christina Acosta

This week we look at infant screen time and anxiety, global pain levels, d-dimer and DVT, and tertiary patents on FDA approved drugs.

Program notes:

0:35 Global pain burden

1:35 Prevalence increased in 15 countries

2:35 Higher prevalence in older people but not consequence of aging

3:02 Tertiary patents

4:03 in the Orange Book

5:05 Prolonged patent protection and higher prices

6:07 Focused on high revenue products

6:50 Detecting DVT better

7:51 Age specific D-dimer cutoffs

8:51 Age and morbidity factors

9:23 Infant screen time and adolescent anxiety

10:24 Multiple intermediate assessments

11:24 Accelerates development

12:47 End

Christina Acosta
Previous

Vaccination in children, CNS medicines in older adults, FDA and mifepristone, and skilled nursing facilities trends
Next

Back pain, private equity and IVF clinics, EKGs and liver disease, and lay health workers